1. Clinical Overview
A fixed-dose combination ophthalmic suspension containing an aminoglycoside antibiotic (Neomycin) and a potent corticosteroid (Fluorometholone). It is primarily indicated for the treatment of steroid-responsive inflammatory ocular conditions where a risk of bacterial infection exists or where such infection is present. The combination provides anti-inflammatory, anti-allergic, and antibacterial coverage.
| Onset | Duration | Bioavailability |
|---|---|---|
| Anti-inflammatory effects of Fluorometholone typically begin within hours, with noticeable improvement in symptoms like redness and swelling often seen within 1-2 days. The antibacterial effect of Neomycin begins upon contact with susceptible organisms. | Topical ocular duration is approximately 4-6 hours per instillation, necessitating multiple daily doses. The anti-inflammatory effect is sustained with regular dosing. | Topical ocular bioavailability is low (<5%) due to minimal systemic absorption from the eye. The drug acts locally. |
2. Mechanism of Action
The combination exerts a dual action: Neomycin binds to the 30S ribosomal subunit of susceptible bacteria, inhibiting protein synthesis and causing bacterial cell death. Fluorometholone binds to cytoplasmic glucocorticoid receptors, triggering anti-inflammatory and immunosuppressive effects by inhibiting phospholipase A2 (reducing prostaglandin/leukotriene synthesis), stabilizing lysosomal membranes, and inhibiting migration of inflammatory cells.
3. Indications & Uses
- Steroid-responsive inflammatory conditions of the palpebral and bulbar conjunctiva, cornea, and anterior segment of the globe (e.g., allergic conjunctivitis, non-infectious keratitis)
- Inflammatory conditions where the risk of ocular bacterial infection is high or where such infection is present
4. Dosage & Administration
Adult Dosage: One or two drops instilled into the conjunctival sac of the affected eye(s) every 4 to 6 hours. In severe conditions, may be used hourly for the first 1-2 days as directed by the physician.
Administration: 1. Wash hands. 2. Shake the suspension well before use. 3. Tilt head back, pull lower eyelid down to form a pouch. 4. Instill prescribed drops without touching the dropper tip to eye or any surface. 5. Close eyes gently for 1-2 minutes, applying gentle pressure to the nasolacrimal duct (inner corner of eye) to minimize systemic absorption. 6. Wait at least 5-10 minutes before instilling any other eye medication.
5. Side Effects
Common side effects may include:
- Transient stinging or burning upon instillation
- Blurred vision temporarily after application
- Mild ocular irritation or itching
- Watery eyes
6. Drug Interactions
| Drug | Effect | Severity |
|---|---|---|
| Other topical ophthalmic corticosteroids | Additive risk of elevated IOP, cataract, and infection. | Major |
| Topical ophthalmic NSAIDs (e.g., Ketorolac, Nepafenac) | May increase risk of corneal healing complications. | Moderate |
| Systemic aminoglycosides (e.g., Gentamicin, Amikacin) | Theoretical additive ototoxicity and nephrotoxicity if significant systemic absorption occurs. | Moderate |
| Neuromuscular blocking agents (e.g., Succinylcholine) | Neomycin may potentiate neuromuscular blockade, risk is extremely low with topical use. | Theoretical |
7. Patient Counselling
- DO shake the bottle well before each use.
- DO wash hands before and after use.
- DO apply gentle pressure on the inner corner of the eye (nasolacrimal duct) for 1-2 minutes after instillation.
- DO wait at least 5-10 minutes before using other eye drops.
- DO NOT touch the dropper tip to your eye, fingers, or any surface.
- DO NOT wear contact lenses during treatment unless specifically advised by your doctor (preservative may be absorbed by lenses).
- DO NOT share your eye drops with anyone.
- DO NOT stop the medication abruptly if used for more than a week; taper as directed.
8. Toxicology & Storage
Overdose: Topical overdose is unlikely to cause acute systemic toxicity. Symptoms would be an extension of side effects: severe ocular irritation, corneal damage, markedly elevated IOP, and if ingested accidentally (from nasolacrimal drainage), possible ototoxicity, nephrotoxicity, and neuromuscular blockade (symptoms: hearing loss, dizziness, respiratory depression).
Storage: Store at controlled room temperature (15°C to 25°C). Protect from light and excessive heat. Do not freeze. Keep the bottle tightly closed when not in use. Discard the bottle 4 weeks after opening to prevent contamination. Keep out of reach and sight of children.